The impact of China’s national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces

BMC Health Services Research

Aitian Yin⁴  Lingui Li¹  Max Petzold³  Ying Bian²  Yan Song² 

[1] College of Management, Ningxia Medical University, 1160 Shengli Street, Yinchuan, Ningxia Province, China;State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Av. Padre Tomás Pereira Taipa, Macau, China;Sahlgrenska Academy, University of Gothenburg, Gothenburg, S-405 30, Sweden;Center for Health Management and Policy, Shandong University, 44 Wenhua Xilu, Jinan, Shandong Province, China

关键词: China;    Primary health care;    Essential medicines policy;    Prescribing behavior;    Rational drug use;   

Others  :  1118233
DOI  :  10.1186/s12913-014-0507-3

 received in 2013-05-24, accepted in 2014-10-09,  发布年份 2014

【 摘 要 】

Background

The National Essential Medicine System (NEMS) is a new policy in China launched in 2009 to improve the appropriate use of medications. This study aims to examine the outcomes of the NEMS objectives in terms of the rational use of medicines in primary health care facilities in China.

Methods

A total of 28,651 prescriptions were collected from 146 township health centers in four provinces of China by means of a field survey conducted in 2010–2011. Indicators of rational drug use were extracted and compared using a pre/post design and then evaluated with regard to the World Health Organization (WHO) Standard Guidelines and data from previous research.

Results

The average number of drugs per prescription decreased from 3.64 to 3.46 (p < 0.01) between 2009 and 2010. Little effect was found for the NEMS on the average number of antibiotics per prescription, but the percentage of prescriptions including antibiotics decreased from 60.26 to 58.48% (p < 0.01). Prescriptions for injections or adrenal corticosteroids also decreased, to 40.31 and 11.16% of all prescriptions, respectively. All these positive issues were also recorded in 2011. However, each of the above values remained higher than WHO standards. The percentage of drugs prescribed from the Essential Drug List increased after the implementation of the NEMS (p < 0.01). Where the available data allowed changes in costs to be assessed, the average expense per prescription increased significantly, from 25.77 to 27.09 yuan (p < 0.01).

Conclusions

The NEMS effectively improved rational medicine use in China. However, polypharmacy and the over-prescription of antibiotics and injections remain common. There is still a large unfinished agenda requiring policy improvements. Treatment guidelines, intensive support supervision, and continuing training for both professionals and consumers are the essential actions that need to be taken.

【 授权许可】

   
2014 Song et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]LeLorier J, Rawson NSB: Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. Can J Cardiol 2007, 23(9):711-718.
• [2]Promoting Rational use of Medicines: Core Components. WHO Policy Perspectives on Medicines. Report WHO/EDM/2002.3. WHO, Geneva; 2002.
• [3]Reynolds L, McKee M: Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy 2009, 90(1):32-36.
• [4]Report of China National Health Accounts. China Health Economics Institute, Beijing; 2009.
• [5]Edwards IR, Aronson JK: Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000, 356(9237):1255-1259.
• [6]Ye K, Wu Y: Rational drug utilization for commonly clinical cases. J China Food Drug Adm 2007, 2:53-55.
• [7][http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.html] webcite China Health Statistical Yearbook. In ᅟ. ; ᅟ []
• [8]How to Investigate Drug use in Health Facilities: Selected Drug use Indicators. Report WHO/DAP/93.1. WHO, Geneva; 1993.
• [9]Quick J, Hogerzeil H, Velasquez G, Rago L: Twenty-five years of essentials medicines. Bull World Health Organ 2002, 80(11):913-914.
• [10][http://archives.who.int/icium/icium1997/posters/1a2_txt.html] webcite Isah AO, Ross-Degnan D, Quick J, Laing R, Mabadeje AFB: The development of standard values for the WHO drug use prescribing indicators. In ᅟ. ; ᅟ []
• [11]Pavin M, Nurgozhin T, Hafner G, Yusufy F, Laing R: Prescribing practices of rural primary health care physicians in Uzbekistan. Trop Med Int Health 2003, 8(2):1889-1890.
• [12]Soumerai S: Factors influencing prescribing. Am J Health Promot 1998, 18:9-16.
• [13]Robert H: Policy evaluation research after twenty years. Policy Stud J 1987, 16(2):191-218.
• [14]Global Strategy for Containment of Antimicrobial Resistance. WHO Communicable Disease Surveillance and Response (CSR). Report WHO/CDS/CSR/DRS/2001.2a. WHO, Geneva; 2001.
• [15]Quick J: Essential medicines twenty-five years on: closing the access gap. Health Policy Plan 2003, 18:1-3.
• [16]Desalegn AA: Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res 2013, 13:170. BioMed Central Full Text
• [17][http://apps.who.int/medicinedocs/en/d/Js6160e/10.html] webcite World Health Organization: The World Medicines Situation. Rational use of Medicines. In []
• [18]Jiang Q, Yu BN, Ying G, Liao J, Gan H, Blanchard J, Zhang J: Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Serv Res 2012, 12:324. BioMed Central Full Text
• [19]Zhuo J, Sleigh AC, Wang H: Unsafe injection and HIV transmission in Guangxi, China. Chin Med J (Engl) 2002, 115(6):960-963.
• [20][http://www.moh.gov.cn/mohywzc/s7652/201110/53137.shtml] webcite China MoH: The establishment of National Essential Medicine System. In []
• [21]Xu J, Fang GX, Jiang QC: Analyzing the prescription cost in village clinics of rural Anhui. Chin Health Serv Manage 2011, 1:25-27.
• [22]Li Y, Ying C, Sufang G, Brant P, Bin L, Hipgrave D: Evaluation, in three provinces, of the introduction and impact of China’s national essential medicines scheme. Bull World Health Organ 2013, 91(3):184-194.
• [23]Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A: Early appraisal of China’s huge and complex health-care reforms. Lancet 2012, 379(9818):833-842.
• [24]Li L, Ye L: The effect of medicine zero profit policy on the drug expenses in primary health centers. Chin J Health Econ Res 2012, 8:30-34.
• [25]Yang HY, Sun Q, Zuo GY, Li K, Meng QY: Changes of drugs’ usage and structure of township hospitals under Essential Medicine System: Cases in three counties of Shandong province. Chin Health Econ 2012, 31(4):59-61.
• [26]Yang L, Liu C, Ferrier JA, Zhou W, Zhang X: The impact of the national essential medicines policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy Plan 2013, 28(7):750-760.